Fortis Healthcare Limited has informed the Exchange about Investor Presentation
FORTIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fortis Healthcare reported strong Q4 FY26 results with consolidated revenues of INR 2,365 Cr (up 17.8% YoY) and PAT of INR 271 Cr (up 44.2% YoY). For full FY26, revenues stood at INR 9,128 Cr (up 17.3%) with operating EBITDA margins expanding to 22.8% vs 20.4% in FY25. Hospital business grew 19.1% to INR 7,773 Cr, driven by 15% increase in occupied beds and 18.9% growth in top 6 specialties. Diagnostics business (Agilus) reported gross revenues of INR 1,527 Cr with margins improving to 23.6%. The company completed acquisitions of People Tree Hospital (Bengaluru) and Shrimann Hospital (Punjab), adding ~500 beds. Net debt increased to INR 2,334 Cr with Net Debt/EBITDA at 1.09x. Board recommended dividend of INR 1 per share.
Strong operational performance with margin expansion signals improved profitability and operational efficiency. The debt-funded acquisitions and planned capacity addition of ~1,800 beds from FY27-FY30 indicate an aggressive growth strategy. The increase in leverage (Net Debt/EBITDA from 0.93x to 1.09x) warrants monitoring.